SERUM LEVELS OF CARBOXYTERMINAL PROPEPTIDE OF TYPE-I PROCOLLAGEN IN HEALTHY-CHILDREN FROM 1ST YEAR OF LIFE TO ADULTHOOD AND IN METABOLIC BONE-DISEASES

被引:69
作者
SAGGESE, G
BERTELLONI, S
BARONCELLI, GI
DINERO, G
机构
[1] Endocrine Unit, Chair of Preventive Paediatrics, Department of Paediatrics, University of Pisa, Pisa, I-56125
关键词
CARBOXYTERMINAL PROPEPTIDE OF TYPE-I PROCOLLAGEN; BONE METABOLISM; PARATHYROID HORMONE RELATED DISEASES; VITAMIN-D RELATED DISEASES; OSTEOPENIA;
D O I
10.1007/BF01959087
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Type I collagen is the major component of bone matrix; circulating carboxyterminal propeptide of type I procollagen (P-I-CP) levels reflect type I collagen synthesis in tissues and may be an useful index to investigate bone metabolism. We measured P-I-CP by a new radioimmunoassay in 300 healthy children and adolescents and in 40 healthy adults to provide reference data for P-I-CP values. In addition, 79 patients with diagnosed disorders of phospho-calcium metabolism (rickets, vitamin D deficient and vitamin D resistant, hyperparathyroidism, hypo- and pseudo-hypoparathyroidism, osteopenia) were evaluated. In the healthy subjects, serum P-I-CP values were higher in children than in adults; variations of P-I-CP levels were observed according to age and sexual maturation: higher values were found in the first years of life and during pubertal development; pubertal increase reflects the different timing of pubertal development in the two sexes. P-I-CP levels were increased in primary hyperparathyroidism and reduced in diseases related to impaired secretion or action of parathyroid hormone. Higher P-I-CP levels were found in vitamin D deficient and vitamin D resistant rickets. P-I-CP was reduced in anorexia nervosa and during chronic glucocorticoid treatment while it was increased in thyrotoxic osteoporosis. In idiopathic juvenile osteoporosis, P-I-CP values ranged from reduced to increased values. We conclude that P-I-CP may represent an additional biochemical marker of bone metabolism. Since age-related variations are present, reference data for the various ages are need for clinical application of this assay.
引用
收藏
页码:764 / 768
页数:5
相关论文
共 24 条
[1]  
AYERS JWT, 1984, FERTIL STERIL, V41, P224
[3]   NEW COLLAGENS, NEW CONCEPTS [J].
BURGESON, RE .
ANNUAL REVIEW OF CELL BIOLOGY, 1988, 4 :551-577
[4]  
CASTELL S, 1990, METABOLIC BONE DISEA, P277
[5]   SERUM OSTEOCALCIN CONCENTRATIONS IN CHILDREN WITH METABOLIC BONE-DISEASE [J].
COLE, DEC ;
CARPENTER, TO ;
GUNDBERG, CM .
JOURNAL OF PEDIATRICS, 1985, 106 (05) :770-776
[6]  
COLLE M, 1989, ARCH FR PEDIATR, V46, P315
[7]  
DANEMAN D, 1982, CLIN ENDOCRINOL META, V1, P211
[8]  
DEWAAL HAD, 1991, HORM RES, V35, P41
[9]   VERTEBRAL BONE-DENSITY IN CHILDREN - EFFECT OF PUBERTY [J].
GILSANZ, V ;
GIBBENS, DT ;
ROE, TF ;
CARLSON, M ;
SENAC, MO ;
BOECHAT, MI ;
HUANG, HK ;
SCHULZ, EE ;
LIBANATI, CR ;
CANN, CC .
RADIOLOGY, 1988, 166 (03) :847-850
[10]   MEASUREMENT OF BONE-MINERAL CONTENT OF THE LUMBAR SPINE BY DUAL ENERGY X-RAY ABSORPTIOMETRY IN NORMAL-CHILDREN - CORRELATIONS WITH GROWTH-PARAMETERS [J].
GLASTRE, C ;
BRAILLON, P ;
DAVID, L ;
COCHAT, P ;
MEUNIER, PJ ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (05) :1330-1333